Your search returned 2 results.

Results
	1.	Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes. [electronic resource] by Lyons, Roger M Cosgriff, Thomas M Modi, Sanjiv S Gersh, Robert H Hainsworth, John D Cohn, Allen L McIntyre, Heidi J Fernando, Indra J Backstrom, Jay T Beach, C L Producer: 20090507 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts. [electronic resource] by Dombret, Hervé Seymour, John F Butrym, Aleksandra Wierzbowska, Agnieszka Selleslag, Dominik Jang, Jun Ho Kumar, Rajat Cavenagh, James Schuh, Andre C Candoni, Anna Récher, Christian Sandhu, Irwindeep Bernal del Castillo, Teresa Al-Ali, Haifa Kathrin Martinelli, Giovanni Falantes, Jose Noppeney, Richard Stone, Richard M Minden, Mark D McIntyre, Heidi Songer, Steve Lucy, Lela M Beach, C L Döhner, Hartmut Producer: 20151019 In: Blood vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search